Shanghai Kehua Bio-engineering Co., Ltd.
Status: Publicly traded
Direct answer
Shanghai Kehua Bio-engineering Co., Ltd. is publicly traded on SHZ under the ticker 002022.SZ.
Shanghai Kehua Bio-Engineering Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of in vitro diagnostic reagents and medical testing equipment and services in China and internationally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated comprehensive...
Can you invest in Shanghai Kehua Bio-engineering Co., Ltd.?
Yes. Shanghai Kehua Bio-engineering Co., Ltd. is publicly traded on SHZ under the ticker 002022.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shanghai Kehua Bio-engineering Co., Ltd.
Detailed equity research is provided by MarketSnap.